Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 561 - 568 of 12007 results

Telephone and Texting Compliance News: Litigation Update — Florida Federal Court Upholds Prior Express Invitation and Draws Distinction to Section 227(b)
September 30, 2024| Article| Viewpoint

2024 Pre-Election Analysis: Financial Services
September 30, 2024| Advisory| Viewpoint

Mintz Venture Watch — Volume 7: A Report on Deal Trends from Q1 and Q2 2024
September 27, 2024| Article| Viewpoint

Qatar Added to List of ESTA/Visa Waiver Eligible Countries
September 27, 2024| Alert| Viewpoint

FTC Staff Report Warns of Privacy Risks in Social Media Companies’ AI Practices — AI: The Washington Report
September 26, 2024| Advisory| Viewpoint

Energy & Sustainability Washington Update — October 2024
September 26, 2024| Article| Viewpoint

Venture Mega-Rounds Return to Biotech
September 26, 2024| News

Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024| News
News & Press Releases
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.
Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|

Health Law Diagnosed: PBM Update Spring 2025
June 10, 2025| Podcast|
